These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20501632)

  • 21. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
    Lopes EC; Scolnik M; Alvarez E; Hajos SE
    Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
    Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
    Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of P-glycoprotein in limiting the brain penetration of glabridin, an active isoflavan from the root of Glycyrrhiza glabra.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Yu XQ; Chowbay B; Wen JY; Duan W; Chan E; Li XT; Cao J; Li CG; Xue CC; Zhou SF
    Pharm Res; 2007 Sep; 24(9):1668-90. PubMed ID: 17551811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces.
    Gazzin S; Strazielle N; Schmitt C; Fevre-Montange M; Ostrow JD; Tiribelli C; Ghersi-Egea JF
    J Comp Neurol; 2008 Oct; 510(5):497-507. PubMed ID: 18680196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
    Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
    J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastoma.
    Becker CM; Oberoi RK; McFarren SJ; Muldoon DM; Pafundi DH; Pokorny JL; Brinkmann DH; Ohlfest JR; Sarkaria JN; Largaespada DA; Elmquist WF
    Neuro Oncol; 2015 Sep; 17(9):1210-9. PubMed ID: 25972455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
    Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A
    J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells.
    Zhu H; Liu Z; Tang L; Liu J; Zhou M; Xie F; Wang Z; Wang Y; Shen S; Hu L; Yu L
    Eur J Pharmacol; 2012 Dec; 696(1-3):43-53. PubMed ID: 23051672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes.
    Declèves X; Regina A; Laplanche JL; Roux F; Boval B; Launay JM; Scherrmann JM
    J Neurosci Res; 2000 Jun; 60(5):594-601. PubMed ID: 10820430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of P-glycoprotein on the brain penetration and brain pharmacodynamic activity of the MEK inhibitor cobimetinib.
    Choo EF; Ly J; Chan J; Shahidi-Latham SK; Messick K; Plise E; Quiason CM; Yang L
    Mol Pharm; 2014 Nov; 11(11):4199-207. PubMed ID: 25243894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3.
    Martell RL; Slapak CA; Levy SB
    Br J Cancer; 1997; 75(2):161-8. PubMed ID: 9010020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.
    Gallo JM; Li S; Guo P; Reed K; Ma J
    Cancer Res; 2003 Aug; 63(16):5114-7. PubMed ID: 12941842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes.
    Mercier C; Declèves X; Masseguin C; Fragner P; Tardy M; Roux F; Gabrion J; Scherrmann JM
    J Neurochem; 2003 Nov; 87(4):820-30. PubMed ID: 14622113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants.
    Cox DS; Scott KR; Gao H; Raje S; Eddington ND
    J Pharm Sci; 2001 Oct; 90(10):1540-52. PubMed ID: 11745712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
    Chen ZS; Aoki S; Komatsu M; Ueda K; Sumizawa T; Furukawa T; Okumura H; Ren XQ; Belinsky MG; Lee K; Kruh GD; Kobayashi M; Akiyama S
    Int J Cancer; 2001 Jul; 93(1):107-13. PubMed ID: 11391629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.
    Agarwal S; Sane R; Gallardo JL; Ohlfest JR; Elmquist WF
    J Pharmacol Exp Ther; 2010 Jul; 334(1):147-55. PubMed ID: 20421331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
    J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway.
    Kong FB; Deng QM; Deng HQ; Dong CC; Li L; He CG; Wang XT; Xu S; Mai W
    Mol Med Rep; 2020 Aug; 22(2):1558-1566. PubMed ID: 32626967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.